Accentia Files Plan Aimed At Boosting MS Drug
Accentia Biopharmaceuticals Inc. has filed a proposed reorganization plan designed to support a key drug development program, moving the company one step closer to emerging from bankruptcy protection as early as...To view the full article, register now.
Already a subscriber? Click here to view full article